History

The key to success is a foundation of excellence.

ACR Image Metrix™ shares an extensive and rich heritage with the American College of Radiology^® (ACR^®), with whom we have been involved for over 400 oncology trials, and the American College of Radiology Imaging Network^® (ACRIN^®). Because of this, ACR Image Metrix can provide a unique perspective and expertise to your clinical trial and imaging modality.

Based on the success of ACRIN, ACR Image Metrix was established in 2007 as a wholly-owned, for-profit subsidiary of ACR, which affords us one-of-a-kind access to world-renowned expertise. Since our inception, we have partnered with over 30 pharmaceutical, biotechnology and medical device manufacturing companies across multiple Phase I-IV trials and registries. Our newly expanded headquarters are located in the ACR Clinical Research Center, adjacent to the ACR imaging and radiation therapy quality assurance core laboratories, which doubled in size in 2009 to meet your growing demands for ACR Image Metrix.

With ACR Image Metrix as your imaging partner, you have an industry leader in image-based drug development and extensive experience in oncology, CNS, cardiovascular, musculoskeletal and other therapeutic categories.